In Nature this week: variability in iPSCs, the silver birch, and more.
Researchers profiled the genotypes and phenotypes for more than 700 induced pluripotent stem cell lines, uncovering between-individual sources of variation.
Under the terms of the deal, Stemcell will distribute Cellular Dynamics' iCell line of induced pluripotent stem cell products.
The firm will use MaxCyte's cell transfection platform to edit hematopoietic stem cells with CRISPR/Cas9 in hemoglobinopathy and SCID.
Researchers found evidence that mutations and age-related methylation signatures tend to persist in induced pluripotent stem cells from the elderly.
The cell lines were edited with CRISPR/Cas9 to create fusions of GFP with the proteins of interest, allowing researchers to image structures in real time.
The researchers said their one-step, inducible, multiplex gene knockdown and gene knockout platforms can be used in many differentiated cell types.
Thermo Fisher said the deal strengthens its portfolio for stem cell research, and it will fold MTI-GlobalStem into its life sciences solutions segment.
The companies will work together to develop human induced pluripotent stem cell-derived cardiomyocytes and neurons for use in drug discovery.
By analyzing the transcriptomes of more than 4,000 individual cells, researchers identified stem cell-like cellular subpopulations in six oligodendroglioma tumors.
Patients who've learned their genetic risk of disease worry about healthcare law changes in the US, Kaiser Health News reports.
Hopkins' Geoffrey Ling discusses the promise of genomic vaccines at Scientific American.
In Nature this week: mitochondrial genome of extinct South American ungulate, and more.
Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.